deltatrials
Completed NA INTERVENTIONAL 2-arm NCT06249841

Feasibility of Cryobiopsy from the Bile Duct - CRYLEO (CRYLEO)

Feasibility of in Vivo Percutaneous Cryobiopsy from the Human Bile Duct - CRYLEO

Sponsor: Erbe Elektromedizin GmbH

Conditions Neoplasms, Bile Duct
Interventions 1.1mm flexible Cryoprobe SU
Updated 6 times since 2024 Last updated: Jan 22, 2025 Started: Mar 4, 2024 Primary completion: Aug 30, 2024 Completion: Aug 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Neoplasms, Bile Duct, this trial is completed. The trial is conducted by Erbe Elektromedizin GmbH and has accumulated 6 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Mar 2024 – ~Apr 2024 · 31 days · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotRecruiting~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshotCompleted~Sep 2025 – present · 11 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Feb 2025 — Sep 2025 [monthly]

    Completed NA

    Status: Recruiting → Completed

  3. Sep 2024 — Feb 2025 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Apr 2024 — Jul 2024 [monthly]

    Recruiting NA

▶ Show 1 earlier version

  1. Mar 2024 — Apr 2024 [monthly]

    Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Erbe Elektromedizin GmbH
Data source: Erbe Elektromedizin GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations